SCHEMBL7002017

SCHEMBL7002017

CC1=C(N)Nc2cc(C#N)ccc2O1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.35
CYP2A6 P11509 2/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SNCA P37840 1/20 0.33
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
ABCB1 P08183 2/20 0.32
EGLN2 Q96KS0 2/20 0.32
CSNK1A1 P48729 1/20 0.31
CSNK1D P48730 1/20 0.31
GSK3B P49841 1/20 0.31
CSNK1G2 P78368 1/20 0.31
IDO1 P14902 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8113309 0.88 KIF11 (0.40) ALDH1A1KDM4E
SCHEMBL28404933 0.79 ABL1 (0.43) ABL1CYP2A6NOS3NOS1NOS2
SCHEMBL5671424 0.78 MMP12 (0.45) ALDH1A1
Hydrochloric Acid SCHEMBL5672533 0.74 AHR (0.38)
SCHEMBL28403165 0.73 ALOX5 (0.41) ABL1CYP2A6NOS3NOS1NOS2
SCHEMBL7988325 0.73 ALDH1A1 (0.36) ALDH1A1KDM4E
SCHEMBL2482795 0.72 ALOX5 (0.59) ABL1CA12CA9
SCHEMBL6994884 0.72 GAA (0.44) ALDH1A1KDM4E
SCHEMBL6999042 0.72 ACE2 (0.47) ABL1ALDH1A1
SCHEMBL7985610 0.71 MMP12 (0.39) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed